JP2005532318A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532318A5 JP2005532318A5 JP2004503446A JP2004503446A JP2005532318A5 JP 2005532318 A5 JP2005532318 A5 JP 2005532318A5 JP 2004503446 A JP2004503446 A JP 2004503446A JP 2004503446 A JP2004503446 A JP 2004503446A JP 2005532318 A5 JP2005532318 A5 JP 2005532318A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- alkyl
- tetrahydro
- disorder
- benzenesulfonamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 19
- 150000001875 compounds Chemical class 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 239000012453 solvate Substances 0.000 claims 6
- 208000016285 Movement disease Diseases 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- -1 nitro, hydroxy Chemical group 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- XGIBOYWYTSHURV-UHFFFAOYSA-N 4-[(4-fluoro-n-methylanilino)methyl]-n-(7-methoxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl)benzenesulfonamide Chemical compound COC1=CC=2CCN(C)CCC=2C=C1NS(=O)(=O)C(C=C1)=CC=C1CN(C)C1=CC=C(F)C=C1 XGIBOYWYTSHURV-UHFFFAOYSA-N 0.000 claims 2
- 208000000044 Amnesia Diseases 0.000 claims 2
- 208000031091 Amnestic disease Diseases 0.000 claims 2
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 206010003805 Autism Diseases 0.000 claims 2
- 208000020706 Autistic disease Diseases 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 2
- 208000017164 Chronobiology disease Diseases 0.000 claims 2
- 206010012289 Dementia Diseases 0.000 claims 2
- 102000015554 Dopamine receptor Human genes 0.000 claims 2
- 108050004812 Dopamine receptor Proteins 0.000 claims 2
- 208000030814 Eating disease Diseases 0.000 claims 2
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 208000028017 Psychotic disease Diseases 0.000 claims 2
- 201000001880 Sexual dysfunction Diseases 0.000 claims 2
- 206010047700 Vomiting Diseases 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 230000006986 amnesia Effects 0.000 claims 2
- 230000036506 anxiety Effects 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 235000014632 disordered eating Nutrition 0.000 claims 2
- 208000002173 dizziness Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000030135 gastric motility Effects 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- CQWQDUVFLPUEPT-UHFFFAOYSA-N n-[7-(dimethylamino)-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl]-2-[(4-fluorophenyl)methyl-methylamino]benzenesulfonamide Chemical compound CN(C)C1=CC=2CCN(C)CCC=2C=C1NS(=O)(=O)C1=CC=CC=C1N(C)CC1=CC=C(F)C=C1 CQWQDUVFLPUEPT-UHFFFAOYSA-N 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 231100000872 sexual dysfunction Toxicity 0.000 claims 2
- 208000019116 sleep disease Diseases 0.000 claims 2
- 208000020685 sleep-wake disease Diseases 0.000 claims 2
- 201000009032 substance abuse Diseases 0.000 claims 2
- 231100000736 substance abuse Toxicity 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 230000008673 vomiting Effects 0.000 claims 2
- ODIMLGQQXYBJNP-UHFFFAOYSA-N 2-[(4-fluorophenyl)methyl-methylamino]-n-(7-methoxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl)benzenesulfonamide Chemical compound COC1=CC=2CCN(C)CCC=2C=C1NS(=O)(=O)C1=CC=CC=C1N(C)CC1=CC=C(F)C=C1 ODIMLGQQXYBJNP-UHFFFAOYSA-N 0.000 claims 1
- ZEQAQYOIKHLGBJ-UHFFFAOYSA-N 4-[(4-chlorophenoxy)methyl]-n-(3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)benzenesulfonamide Chemical compound C1=C2CCN(C)CCC2=CC=C1NS(=O)(=O)C(C=C1)=CC=C1COC1=CC=C(Cl)C=C1 ZEQAQYOIKHLGBJ-UHFFFAOYSA-N 0.000 claims 1
- JCQCCKPYMFTKEZ-UHFFFAOYSA-N 4-[(4-fluoroanilino)methyl]-n-(7-methoxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl)benzenesulfonamide Chemical compound COC1=CC=2CCN(C)CCC=2C=C1NS(=O)(=O)C(C=C1)=CC=C1CNC1=CC=C(F)C=C1 JCQCCKPYMFTKEZ-UHFFFAOYSA-N 0.000 claims 1
- MBVRCXXXZOQDLV-UHFFFAOYSA-N 4-[(4-fluorophenyl)methylamino]-n-(7-methoxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl)benzenesulfonamide Chemical compound COC1=CC=2CCN(C)CCC=2C=C1NS(=O)(=O)C(C=C1)=CC=C1NCC1=CC=C(F)C=C1 MBVRCXXXZOQDLV-UHFFFAOYSA-N 0.000 claims 1
- 206010001488 Aggression Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 230000016571 aggressive behavior Effects 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 1
- JWRYECYECNQKBA-UHFFFAOYSA-N n-(7-bromo-2,3,4,5-tetrahydro-1h-3-benzazepin-8-yl)-4-phenylmethoxybenzenesulfonamide Chemical compound BrC1=CC=2CCNCCC=2C=C1NS(=O)(=O)C(C=C1)=CC=C1OCC1=CC=CC=C1 JWRYECYECNQKBA-UHFFFAOYSA-N 0.000 claims 1
- WUOGOMGYDQUACG-UHFFFAOYSA-N n-[5-(dimethylamino)-5-methyl-1,2,3,4-tetrahydro-3-benzazepin-8-yl]-4-[(4-fluoro-n-methylanilino)methyl]benzenesulfonamide Chemical compound C=1C=C2C(N(C)C)(C)CNCCC2=CC=1NS(=O)(=O)C(C=C1)=CC=C1CN(C)C1=CC=C(F)C=C1 WUOGOMGYDQUACG-UHFFFAOYSA-N 0.000 claims 1
- ZCSBJGGGFCDTHY-UHFFFAOYSA-N n-[7-(dimethylamino)-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl]-4-[(4-fluorophenyl)methoxy]benzenesulfonamide Chemical compound CN(C)C1=CC=2CCN(C)CCC=2C=C1NS(=O)(=O)C(C=C1)=CC=C1OCC1=CC=C(F)C=C1 ZCSBJGGGFCDTHY-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210762.1A GB0210762D0 (en) | 2002-05-10 | 2002-05-10 | Compounds |
| PCT/GB2003/001983 WO2003095428A1 (en) | 2002-05-10 | 2003-05-09 | Dopamine receptor modulators as antipsychotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532318A JP2005532318A (ja) | 2005-10-27 |
| JP2005532318A5 true JP2005532318A5 (cg-RX-API-DMAC7.html) | 2006-06-29 |
Family
ID=9936447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004503446A Pending JP2005532318A (ja) | 2002-05-10 | 2003-05-09 | 抗精神病薬としてのドーパミン受容体モジュレーター |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070043026A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1503989A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005532318A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003227919A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0210762D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003095428A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY133587A (en) | 2002-05-29 | 2007-11-30 | Glaxo Group Ltd | Aromatic sulfones and their medical use |
| GB0329214D0 (en) * | 2003-12-17 | 2004-01-21 | Glaxo Group Ltd | Novel compounds |
| US20050137186A1 (en) * | 2003-12-18 | 2005-06-23 | Abbott Gmbh & Co. Kg. | Tetrahydrobenzazepines and their use |
| US8207160B2 (en) | 2003-12-18 | 2012-06-26 | Abbott Gmbh & Co. Kg | Tetrahydrobenzazepines and their use in he modulation of the dopamine D3 receptor |
| TW200611701A (en) * | 2004-06-18 | 2006-04-16 | Glaxo Group Ltd | Novel compounds |
| EP2371814A1 (en) * | 2004-10-14 | 2011-10-05 | Abbott GmbH & Co. KG | Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| EP1837332A1 (en) * | 2006-03-23 | 2007-09-26 | Laboratorios Del Dr. Esteve, S.A. | Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
| US7897595B2 (en) | 2006-05-26 | 2011-03-01 | Forest Laboratories Holdings Limited | Pyridoazepine derivatives |
| US8258134B2 (en) * | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321254A (en) * | 1980-09-26 | 1982-03-23 | Smithkline Corporation | Antiallergic imidodisulfamides |
| US5112824A (en) * | 1989-12-08 | 1992-05-12 | Merck & Co., Inc. | Benzofuran compounds as class III antiarrhythmic agents |
| US5684195A (en) * | 1994-07-14 | 1997-11-04 | G. D. Searle & Co. | Method of preparing sulfmonamides from sulfones |
| NZ332757A (en) * | 1996-06-17 | 1999-06-29 | Smithkline Beecham Plc | Substituted tetrahydroisoquinoline benzamide derivatives and their use as anticonvulsants and psycho-active agents |
| IL131756A0 (en) * | 1997-03-18 | 2001-03-19 | Smithkline Beecham Plc | Substituted isoquinoline derivatives and their use as anticonvulsants |
| JP2001521026A (ja) * | 1997-10-24 | 2001-11-06 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 置換イソキノリン誘導体および抗痙攣薬としての使用 |
| DE10053799A1 (de) * | 2000-10-30 | 2002-05-08 | Bayer Ag | Verwendung von Tetrahydroisochinolinsulfonamiden |
-
2002
- 2002-05-10 GB GBGB0210762.1A patent/GB0210762D0/en not_active Ceased
-
2003
- 2003-05-09 AU AU2003227919A patent/AU2003227919A1/en not_active Abandoned
- 2003-05-09 JP JP2004503446A patent/JP2005532318A/ja active Pending
- 2003-05-09 EP EP03725384A patent/EP1503989A1/en not_active Withdrawn
- 2003-05-09 US US10/513,919 patent/US20070043026A1/en not_active Abandoned
- 2003-05-09 WO PCT/GB2003/001983 patent/WO2003095428A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005518414A5 (cg-RX-API-DMAC7.html) | ||
| CN1131212C (zh) | 苯基-和吡啶基衍生物 | |
| HUP0300350A2 (hu) | Új 3-amino-azetidin-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
| JP2005526723A5 (cg-RX-API-DMAC7.html) | ||
| JP2006519258A5 (cg-RX-API-DMAC7.html) | ||
| JP2004509162A (ja) | アミノアルコール誘導体 | |
| JP2012502986A5 (cg-RX-API-DMAC7.html) | ||
| MXPA05000196A (es) | Derivados de 1-amido-4-fenil-4-benciloximetil-piperidina y compuestos relacionados como antagonistas de neurocinina-1(nk-1)para el tratamiento de vomito, depresion, ansiedad y tos. | |
| RU2009138219A (ru) | Новые бензамидные производные и способ их получения | |
| RU2008127501A (ru) | Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов | |
| RU2001130169A (ru) | Производные карбаминовой кислоты и их применение в качестве лигандов метаботропных глутаматных рецепторов | |
| CA2702933A1 (en) | Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof | |
| JP2005513016A5 (cg-RX-API-DMAC7.html) | ||
| RU2006105777A (ru) | Индол-6-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6 | |
| CA2529126A1 (en) | Azetidine compounds | |
| RU2006105779A (ru) | Индол-5-ильные сульфонамидные производные, их получение и их применение в качестве модуляторов 5-нт-6 | |
| JP2008542365A5 (cg-RX-API-DMAC7.html) | ||
| WO2010040274A1 (zh) | 新型多巴胺d3受体配体,其制备方法及其医药用途 | |
| JP2006525297A5 (cg-RX-API-DMAC7.html) | ||
| JP2006519812A (ja) | フェニルスルホン誘導体およびcns障害の治療におけるその使用 | |
| RU2156250C2 (ru) | Производные хромона, способ их получения и фармацевтическая композиция | |
| TWI423967B (zh) | 醯胺衍生物及含有其之醫藥組合物 | |
| CN1063177C (zh) | 治疗偏头痛的吲哚烷基-吡啶基和嘧啶基哌嗪的1,2,5-噻二唑衍生物 | |
| CN105916850A (zh) | 作为激酶抑制剂的取代的二烷基(氧撑)-λ4-硫烷亚基烟酰胺衍生物 | |
| CN101160295A (zh) | 3,4-二氢-苯并[e][1,3]嗪-2-酮类化合物 |